vs
美国合众银行（EBMT）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
美国合众银行的季度营收约是ROCKWELL MEDICAL, INC.的1.3倍（$24.3M vs $18.3M），美国合众银行净利率更高（19.5% vs -3.0%，领先22.5%），美国合众银行同比增速更快（13.7% vs -25.6%），美国合众银行自由现金流更多（$28.3M vs $2.2M），过去两年美国合众银行的营收复合增速更高（12.6% vs -10.1%）
美国合众银行是一家美国跨国银行金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押贷款等金融业务。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
EBMT vs RMTI — 直观对比
营收规模更大
EBMT
是对方的1.3倍
$18.3M
营收增速更快
EBMT
高出39.3%
-25.6%
净利率更高
EBMT
高出22.5%
-3.0%
自由现金流更多
EBMT
多$26.1M
$2.2M
两年增速更快
EBMT
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.3M | $18.3M |
| 净利润 | $4.7M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | 25.0% | -2.2% |
| 净利率 | 19.5% | -3.0% |
| 营收同比 | 13.7% | -25.6% |
| 净利润同比 | 37.8% | 26.7% |
| 每股收益（稀释后） | $0.62 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EBMTRMTI
| Q4 25 | $24.3M | $18.3M | ||
| Q3 25 | $23.4M | $15.9M | ||
| Q2 25 | $23.0M | $16.1M | ||
| Q1 25 | $20.9M | $18.9M | ||
| Q4 24 | $21.4M | $24.7M | ||
| Q3 24 | $20.8M | $28.3M | ||
| Q2 24 | $19.9M | $25.8M | ||
| Q1 24 | $19.2M | $22.7M |
净利润EBMTRMTI
| Q4 25 | $4.7M | $-554.0K | ||
| Q3 25 | $3.6M | $-1.8M | ||
| Q2 25 | $3.2M | $-1.5M | ||
| Q1 25 | $3.2M | $-1.5M | ||
| Q4 24 | $3.4M | $-756.0K | ||
| Q3 24 | $2.7M | $1.7M | ||
| Q2 24 | $1.7M | $343.0K | ||
| Q1 24 | $1.9M | $-1.7M |
毛利率EBMTRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率EBMTRMTI
| Q4 25 | 25.0% | -2.2% | ||
| Q3 25 | 21.2% | -9.9% | ||
| Q2 25 | 17.4% | -8.4% | ||
| Q1 25 | 18.5% | -7.2% | ||
| Q4 24 | 17.3% | -2.1% | ||
| Q3 24 | 15.6% | 6.8% | ||
| Q2 24 | 11.0% | 2.0% | ||
| Q1 24 | 11.8% | -5.8% |
净利率EBMTRMTI
| Q4 25 | 19.5% | -3.0% | ||
| Q3 25 | 15.5% | -11.0% | ||
| Q2 25 | 14.1% | -9.3% | ||
| Q1 25 | 15.5% | -8.0% | ||
| Q4 24 | 16.1% | -3.1% | ||
| Q3 24 | 13.0% | 5.9% | ||
| Q2 24 | 8.7% | 1.3% | ||
| Q1 24 | 9.9% | -7.6% |
每股收益（稀释后）EBMTRMTI
| Q4 25 | $0.62 | $-0.01 | ||
| Q3 25 | $0.46 | $-0.05 | ||
| Q2 25 | $0.41 | $-0.05 | ||
| Q1 25 | $0.41 | $-0.04 | ||
| Q4 24 | $0.44 | $-0.02 | ||
| Q3 24 | $0.34 | $0.04 | ||
| Q2 24 | $0.22 | $0.01 | ||
| Q1 24 | $0.24 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.0M | $10.7M |
| 总债务越低越好 | $44.5M | — |
| 股东权益账面价值 | $191.8M | $37.0M |
| 总资产 | $2.1B | $57.1M |
| 负债/权益比越低杠杆越低 | 0.23× | — |
8季度趋势，按日历期对齐
现金及短期投资EBMTRMTI
| Q4 25 | $63.0M | $10.7M | ||
| Q3 25 | $29.5M | $13.6M | ||
| Q2 25 | $26.9M | $12.5M | ||
| Q1 25 | $22.8M | $11.4M | ||
| Q4 24 | $31.6M | $15.7M | ||
| Q3 24 | $42.2M | $12.3M | ||
| Q2 24 | $23.8M | $11.9M | ||
| Q1 24 | $20.9M | $6.6M |
总债务EBMTRMTI
| Q4 25 | $44.5M | — | ||
| Q3 25 | $59.3M | — | ||
| Q2 25 | $59.2M | — | ||
| Q1 25 | $59.2M | — | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $59.1M | — | ||
| Q2 24 | $59.1M | — | ||
| Q1 24 | $59.0M | — |
股东权益EBMTRMTI
| Q4 25 | $191.8M | $37.0M | ||
| Q3 25 | $186.5M | $37.0M | ||
| Q2 25 | $180.6M | $30.4M | ||
| Q1 25 | $177.6M | $31.5M | ||
| Q4 24 | $174.8M | $32.6M | ||
| Q3 24 | $177.7M | $29.1M | ||
| Q2 24 | $170.2M | $23.5M | ||
| Q1 24 | $168.9M | $20.6M |
总资产EBMTRMTI
| Q4 25 | $2.1B | $57.1M | ||
| Q3 25 | $2.1B | $57.5M | ||
| Q2 25 | $2.1B | $52.6M | ||
| Q1 25 | $2.1B | $54.0M | ||
| Q4 24 | $2.1B | $59.2M | ||
| Q3 24 | $2.1B | $57.1M | ||
| Q2 24 | $2.1B | $53.0M | ||
| Q1 24 | $2.1B | $50.7M |
负债/权益比EBMTRMTI
| Q4 25 | 0.23× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.1M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $28.3M | $2.2M |
| 自由现金流率自由现金流/营收 | 116.7% | 12.0% |
| 资本支出强度资本支出/营收 | 19.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 7.01× | — |
| 过去12个月自由现金流最近4个季度 | $37.1M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流EBMTRMTI
| Q4 25 | $33.1M | $2.3M | ||
| Q3 25 | $9.0M | $-1.3M | ||
| Q2 25 | $1.7M | $1.8M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $28.5M | $865.0K | ||
| Q3 24 | $2.6M | $4.3M | ||
| Q2 24 | $3.3M | $1.4M | ||
| Q1 24 | $7.1M | $-2.4M |
自由现金流EBMTRMTI
| Q4 25 | $28.3M | $2.2M | ||
| Q3 25 | $7.1M | $-1.5M | ||
| Q2 25 | $1.4M | $1.7M | ||
| Q1 25 | $262.0K | $-3.5M | ||
| Q4 24 | $14.5M | $470.0K | ||
| Q3 24 | $-749.0K | $4.1M | ||
| Q2 24 | $627.0K | $1.2M | ||
| Q1 24 | $2.3M | $-2.5M |
自由现金流率EBMTRMTI
| Q4 25 | 116.7% | 12.0% | ||
| Q3 25 | 30.3% | -9.6% | ||
| Q2 25 | 6.0% | 10.5% | ||
| Q1 25 | 1.3% | -18.8% | ||
| Q4 24 | 67.7% | 1.9% | ||
| Q3 24 | -3.6% | 14.4% | ||
| Q2 24 | 3.2% | 4.5% | ||
| Q1 24 | 12.2% | -11.1% |
资本支出强度EBMTRMTI
| Q4 25 | 19.7% | 0.5% | ||
| Q3 25 | 8.0% | 1.4% | ||
| Q2 25 | 1.6% | 1.0% | ||
| Q1 25 | 7.8% | 0.3% | ||
| Q4 24 | 65.9% | 1.6% | ||
| Q3 24 | 16.1% | 0.7% | ||
| Q2 24 | 13.3% | 1.1% | ||
| Q1 24 | 24.9% | 0.6% |
现金转化率EBMTRMTI
| Q4 25 | 7.01× | — | ||
| Q3 25 | 2.47× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 8.31× | — | ||
| Q3 24 | 0.96× | 2.57× | ||
| Q2 24 | 1.88× | 4.20× | ||
| Q1 24 | 3.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EBMT
| Other | $13.2M | 54% |
| Commodity Sales | $8.6M | 35% |
| Bank Servicing | $2.6M | 11% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
